Elevance Health Reports Fourth Quarter and Full Year 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Elevance Health Inc. (ELV) Tops Q4 EPS by 3c; Offers 2023 Guidance
January 25, 2023 6:07 AM ESTElevance Health Inc. (NYSE: ELV) reported Q4 EPS of $5.23, $0.03 better than the analyst estimate of $5.20. Revenue for the quarter came in at $39.67 billion versus the consensus estimate of $39.72 billion.
GUIDANCE:
Elevance Health Inc. sees FY2023 EPS of $32.60, versus the consensus of... More
